243 related articles for article (PubMed ID: 16971699)
1. Infusion of platelets transiently reduces nucleoside overload in MNGIE.
Lara MC; Weiss B; Illa I; Madoz P; Massuet L; Andreu AL; Valentino ML; Anikster Y; Hirano M; Martí R
Neurology; 2006 Oct; 67(8):1461-3. PubMed ID: 16971699
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): biochemical features and therapeutic approaches.
Lara MC; Valentino ML; Torres-Torronteras J; Hirano M; Martí R
Biosci Rep; 2007 Jun; 27(1-3):151-63. PubMed ID: 17549623
[TBL] [Abstract][Full Text] [Related]
3. Treatment of mitochondrial neurogastrointestinal encephalomyopathy with dialysis.
Yavuz H; Ozel A; Christensen M; Christensen E; Schwartz M; Elmaci M; Vissing J
Arch Neurol; 2007 Mar; 64(3):435-8. PubMed ID: 17353390
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE): a disease of two genomes.
Hirano M; Nishigaki Y; Martí R
Neurologist; 2004 Jan; 10(1):8-17. PubMed ID: 14720311
[TBL] [Abstract][Full Text] [Related]
5. Late-onset MNGIE due to partial loss of thymidine phosphorylase activity.
Martí R; Verschuuren JJ; Buchman A; Hirano I; Tadesse S; van Kuilenburg AB; van Gennip AH; Poorthuis BJ; Hirano M
Ann Neurol; 2005 Oct; 58(4):649-52. PubMed ID: 16178026
[TBL] [Abstract][Full Text] [Related]
6. Definitive diagnosis of mitochondrial neurogastrointestinal encephalomyopathy by biochemical assays.
Martí R; Spinazzola A; Tadesse S; Nishino I; Nishigaki Y; Hirano M
Clin Chem; 2004 Jan; 50(1):120-4. PubMed ID: 14633909
[TBL] [Abstract][Full Text] [Related]
7. Treating MNGIE: is reducing blood nucleosides the first cure for a mitochondrial disorder?
Chinnery PF; Vissing J
Neurology; 2006 Oct; 67(8):1330-2. PubMed ID: 17060555
[No Abstract] [Full Text] [Related]
8. Allogeneic stem cell transplantation corrects biochemical derangements in MNGIE.
Hirano M; Martí R; Casali C; Tadesse S; Uldrick T; Fine B; Escolar DM; Valentino ML; Nishino I; Hesdorffer C; Schwartz J; Hawks RG; Martone DL; Cairo MS; DiMauro S; Stanzani M; Garvin JH; Savage DG
Neurology; 2006 Oct; 67(8):1458-60. PubMed ID: 16971696
[TBL] [Abstract][Full Text] [Related]
9. Assessment of thymidine phosphorylase function: measurement of plasma thymidine (and deoxyuridine) and thymidine phosphorylase activity.
Martí R; López LC; Hirano M
Methods Mol Biol; 2012; 837():121-33. PubMed ID: 22215544
[TBL] [Abstract][Full Text] [Related]
10. Thymidine phosphorylase mutations cause instability of mitochondrial DNA.
Hirano M; Lagier-Tourenne C; Valentino ML; Martí R; Nishigaki Y
Gene; 2005 Jul; 354():152-6. PubMed ID: 15975738
[TBL] [Abstract][Full Text] [Related]
11. Thymidine phosphorylase gene mutations in patients with mitochondrial neurogastrointestinal encephalomyopathy syndrome.
Slama A; Lacroix C; Plante-Bordeneuve V; Lombès A; Conti M; Reimund JM; Auxenfants E; Crenn P; Laforêt P; Joannard A; Seguy D; Pillant H; Joly P; Haut S; Messing B; Said G; Legrand A; Guiochon-Mantel A
Mol Genet Metab; 2005 Apr; 84(4):326-31. PubMed ID: 15781193
[TBL] [Abstract][Full Text] [Related]
12. Non-myeloablative bone marrow transplant and platelet infusion can transiently improve the clinical outcome of mitochondrial neurogastrointestinal encephalopathy: a case report.
Hussein E
Transfus Apher Sci; 2013 Oct; 49(2):208-11. PubMed ID: 23410918
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial Neurogastrointestinal Encephalomyopathy Treated with Stem Cell Transplantation: A Case Report and Review of Literature.
Peedikayil MC; Kagevi EI; Abufarhaneh E; Alsayed MD; Alzahrani HA
Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):85-90. PubMed ID: 25585305
[TBL] [Abstract][Full Text] [Related]
14. Pre- and post-dialysis quantitative dosage of thymidine in urine and plasma of a MNGIE patient by using HPLC-ESI-MS/MS.
la Marca G; Malvagia S; Casetta B; Pasquini E; Pela I; Hirano M; Donati MA; Zammarchi E
J Mass Spectrom; 2006 May; 41(5):586-92. PubMed ID: 16498612
[TBL] [Abstract][Full Text] [Related]
15. HPLC-UV analysis of thymidine and deoxyuridine in plasma of patients with thymidine phosphorylase deficiency.
Mohamed S; Caporali L; De Giorgio R; Carelli V; Contin M
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Feb; 949-950():58-62. PubMed ID: 24463401
[TBL] [Abstract][Full Text] [Related]
16. A novel ECGF1 mutation in a Thai patient with mitochondrial neurogastrointestinal encephalomyopathy (MNGIE).
Kintarak J; Liewluck T; Sangruchi T; Hirano M; Kulkantrakorn K; Muengtaweepongsa S
Clin Neurol Neurosurg; 2007 Sep; 109(7):613-6. PubMed ID: 17544574
[TBL] [Abstract][Full Text] [Related]
17. Hemodialysis in MNGIE transiently reduces serum and urine levels of thymidine and deoxyuridine, but not CSF levels and neurological function.
Röeben B; Marquetand J; Bender B; Billing H; Haack TB; Sanchez-Albisua I; Schöls L; Blom HJ; Synofzik M
Orphanet J Rare Dis; 2017 Aug; 12(1):135. PubMed ID: 28764801
[TBL] [Abstract][Full Text] [Related]
18. [Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE)].
Honzík T; Tesarová M; Hansíková H; Krijt J; Benes P; Zámecník J; Wenchich L; Zeman J
Cas Lek Cesk; 2006; 145(8):665-70. PubMed ID: 16995425
[TBL] [Abstract][Full Text] [Related]
19. Four novel thymidine phosphorylase gene mutations in mitochondrial neurogastrointestinal encephalomyopathy syndrome (MNGIE) patients.
Kocaefe YC; Erdem S; Ozgüç M; Tan E
Eur J Hum Genet; 2003 Jan; 11(1):102-4. PubMed ID: 12529715
[TBL] [Abstract][Full Text] [Related]
20. Elevated plasma deoxyuridine in patients with thymidine phosphorylase deficiency.
Martí R; Nishigaki Y; Hirano M
Biochem Biophys Res Commun; 2003 Mar; 303(1):14-8. PubMed ID: 12646159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
